Update on Humira Biosimilars and Navitus' Standard Formularies

Humira Biosimilars Enter the Marketplace – Update on Navitus’ Review

The market entry of biosimilars to Humira® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...

Read More
News, Insider, Specialty
Five Forecasts for Plan Sponsors in 2023

Five Forecasts and Takeaways for Plan Sponsors in 2023

As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.

Read More
News, Insider, Specialty

Key Findings: 2021 Navitus Drug Trend Report

This week we provide an overview of our 2021 drug trend and client savings with insights for 2022 and beyond.

Read More
Insider

What You Need to Know About Fraud, Waste and Abuse in The Age of COVID-19

Carrie Aiken, Navitus’ Vice President of Corporate Compliance and Chief Compliance Officer, shares her perspective on how PBMs can help plan sponsors...

Read More
News, Insider

Using PMPM to Measure True Bottom Line Costs

Comparing one PBM to another is very complex. To add to it, many metrics are available to help you understand if you’re getting a good deal or not....

Read More
Insider
2022 PBM trends for plan sponsors

2022 Pharmacy Benefit Predictions: What Plan Sponsors Should Watch

Navitus’ CEO, David Fields, shares his insights into the pharmacy benefits industry that will help plan sponsors achieve greater cost savings,...

Read More
Insider, Specialty

In the Pipeline: Specialty Drugs to Watch in 2022

Specialty medication development has grown rapidly, encompassing up to 80% of new FDA drug approvals in recent years. Read on to learn about the most...

Read More
Insider, Specialty

In the Pipeline: Non-Specialty Drugs to Watch in 2022

Our pharmacists are always monitoring the drug development pipeline to help plan sponsors stay ahead of the curve on new and upcoming medications....

Read More
Insider

Using UM Strategies to Better Manage Rx Costs and Improve Health (rerun)

Utilization management (UM) programs serve as a gatekeeper to the formulary, working to ensure appropriate, cost-effective medication use. They can...

Read More
Insider
3 Key Revenue Streams You Need to Know

3 Key PBM Revenue Streams You Need to Know

Understanding how pharmacy benefit managers (PBMs) make money can help plan sponsors determine which PBM business model is best for their Rx plan –...

Read More
Insider, Podcast

Subscribe Here!

Content not found